GURUFOCUS.COM » STOCK LIST » USA » NAS » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Profitability Rank
Switch to:

CollPlant Biotechnologies Profitability Rank

: 3 (As of Mar. 2022)
View and export this data going back to 2021. Start your Free Trial

CollPlant Biotechnologies has the Profitability Rank of 3. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

CollPlant Biotechnologies's Operating Margin % for the quarter that ended in Mar. 2022 was -5,709.09%. As of today, CollPlant Biotechnologies's Piotroski F-Score is 4.


Competitive Comparison

For the Biotechnology subindustry, CollPlant Biotechnologies's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

CollPlant Biotechnologies Profitability Rank Distribution

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Profitability Rank distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Profitability Rank falls into.



CollPlant Biotechnologies Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

CollPlant Biotechnologies has the Profitability Rank of 3. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

CollPlant Biotechnologies's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2022 ) / Revenue (Q: Mar. 2022 )
=-3.768 / 0.066
=-5,709.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

CollPlant Biotechnologies has an F-score of 4 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


CollPlant Biotechnologies Profitability Rank Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies Business Description

CollPlant Biotechnologies logo
Traded in Other Exchanges
N/A
Address
4 Oppenheimer Street, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

CollPlant Biotechnologies Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)